An interventional study of Caudal Block with Ropivacaine Intervention and Local Wound Infiltration with Ropivacaine Intervention in Postoperative Pain, sponsored by Fatima Memorial Hospital. Completed at 1 site in Pakistan. Open to participants aged 2 Years to 10 Years. Per ClinicalTrials.gov, last updated 2026-08-05.
Sponsored by Fatima Memorial Hospital · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 137 studies in Pain, Postoperative with a site in Pakistan — 41 open to participants now, 45 under way, 5 of them phase 3. Pain, Postoperative · Pakistan.
Among the 137 studies in Pain, Postoperative with a site in Pakistan, this one is the 34th largest by enrollment of the 135 interventional ones that give a count, is one of 29 that started in 2025, is one of 86 with no phase, and was the 116th registered.
5,680 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.
Browse Pain, Postoperative studies →41 of the 137 studies in Pain, Postoperative with a site in Pakistan are open now. Recruiting first, the newest first:
Khyber Medical University Peshawar · Sites in Pakistan
Ages 18–40 · Healthy volunteers
Shaukat Khanum Memorial Cancer Hospital & Research Centre · Sites in Pakistan
Ages 18+
Wah Medical college , POF hospital · Sites in Pakistan
Ages 18–60
King Edward Medical University · Sites in Pakistan
Ages 18–60
Quaid-e-Azam Medical College · Sites in Pakistan
Ages 1–15
A study can be open while its sites in Pakistan have not opened yet or have stopped. Only those recruiting at a site in Pakistan →
Of the 678 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.
This study: 2 Years to 10 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
137 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 12 · Phase 2 13 · Phase 3 13 · Phase 4 20
First in 2014; this study’s year is marked. 29 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 100 is above the median of 75 across 4,859 interventional studies indexed under Pain, Postoperative.
Median enrollment 78 across the 135 interventional studies, 60 across the 2 observational. Of the 77 that completed or were terminated, 3 (4%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 137 has an industry lead sponsor. The 10 most frequent:
Fatima Memorial Hospital is the lead sponsor of 12 studies on the registry; 3 are open to participants now.
Fatima Memorial Hospital has 6 studies filed under Pain, Postoperative — fewer than ten, so there is no comparison to draw.
16 of the studies in Pain, Postoperative with a site in Pakistan that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06996561Phase 3Dr. Asma Abdus SalamExploring the Impact of Genetic Variations on The Clinical Efficacy of Nalbuphine in Postoperative Pain Management | 2027-01-01 |
| NCT07779551Sargodha Medical CollegeComparison of Two Drugs Bupivacaine and Ropivacaine for Postoperative Analgesia in Bilateral Superficial Cervical Plexus Block After Thyroidectomy | 2026-12 |
| NCT07650760Wah Medical college , POF hospitalComparison of Intraperitoneal Bupivacaine and Saline Irrigation for Pain Relief After Laparoscopic Cholecystectomy | 2026-12 |
| NCT07775053Sargodha Medical CollegeEfficacy of Tramadol With Ropivacaine for Modified Pectoral Nerve Block in Breast Cancer Surgery | 2026-12-31 |
| NCT07338006University of Health Sciences LahoreChest Wall Reconstruction Cohort | 2026-12-31 |
Add all 16 to your calendar (.ics) → With an account.
Among the 137 studies in Pain, Postoperative with a site in Pakistan, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This randomized controlled trial aims to compare the analgesic efficacy of local wound infiltration with Ropivacaine versus Caudal Block with Ropivacaine in pediatric patients undergoing surgery for inguinal hernia
Pediatric patients undergoing inguinal hernia surgeries experience postoperative pain. Conventional pain management methods, including opiates, may pose significant side effects. This study addresses the imperative need for optimizing postoperative pain management by systematically investigating and comparing the analgesic effects of local wound infiltration versus caudal block. The study involves 100 patients allocated into two equal groups using a lottery method: one group receiving caudal block; and other group local wound infiltration . Post-operative pain will be assessed at 30 minutes, and 1, 2, 4, 6, and 8 hours using the Hannallah Modified Objective Pain Scale. At any stage, if a pain score of 3 or more is observed, it will be considered severe pain, and rescue analgesia in intravenous paracetamol suspension at 15 ml/kg body weight will be administered.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Pediatric patients undergoing open elective inguinal herniotomy who receive a post-operative caudal block.
Drug: Caudal Block with Ropivacaine Intervention · Drug: Intravenous Paracetamol Suspension Intervention
Pediatric patients undergoing open elective inguinal herniotomy who receive post-operative local wound infiltration.
Drug: Local Wound Infiltration with Ropivacaine Intervention · Drug: Intravenous Paracetamol Suspension Intervention
Administered after surgery using the landmark technique with 0.25% ropivacaine at a dose of 2mg/kg body weight.
Administered after surgery by pediatric surgeons using 0.5% ropivacaine at a dose of 2mg/kg body weight into the groin skin crease incision.
Administered as rescue analgesia at a dose of 15 ml/kg body weight if the patient's postoperative pain score reaches 3 or higher on the Hannallah Modified Objective Pain Scale.
Postoperative Analgesic Requirement
Post-operative pain will be assessed at 30 minutes, and 1, 2, 4, 6, and 8 hours using the Hannallah Modified Objective Pain Scale. At any stage, if a pain score of 3 or more is observed, it will be considered severe pain, and rescue analgesia in intravenous paracetamol suspension at 15 ml/kg body weight will be administered.
Time frame: Within first 8 hours after surgery
Postoperative Analgesia requirement
Post-operative pain will be assessed at 30 minutes, and 1, 2, 4, 6, and 8 hours using the Hannallah Modified Objective Pain Scale. At any stage, if a pain score of 3 or more is observed, it will be considered severe pain, and rescue analgesia in intravenous paracetamol suspension at 15 ml/kg body weight will be administered.
Time frame: Within first 8 hours after surgery
Plan to share: No
No publications or documents are linked to this record.
Ran from Jul 2025 to primary completion in Jul 2026, 12 months.
Of 2,113 non-industry interventional studies with no phase under Pain, Postoperative, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's 12 months is close to that.
Counting every sponsor, half of 2,126 studies reached it within 11 months; a quarter within 6 and three quarters within 23.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Fatima Memorial Hospital